» Articles » PMID: 36879263

HLA Typing of Patients Who Developed Subacute Thyroiditis and Graves' Disease After SARS-CoV-2 Vaccination: a Case Report

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2023 Mar 6
PMID 36879263
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cases of subacute thyroiditis (SAT) after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination have been reported. A human leukocyte antigen (HLA) allele, HLA-B*35, appears to be involved in the pathogenesis of SAT.

Case Presentation: We conducted HLA typing of one patient with SAT and another with both SAT and Graves' disease (GD), which developed after SARS-CoV-2 vaccination. Patient 1, a 58-year-old Japanese man, was inoculated with a SARS-CoV-2 vaccine (BNT162b2; Pfizer, New York, NY, USA). He developed fever (38 °C), cervical pain, palpitations, and fatigue on day 10 after vaccination. Blood chemistry tests revealed thyrotoxicosis and elevated serum C-reactive protein (CRP) and slightly increased serum antithyroid-stimulating antibody (TSAb) levels. Thyroid ultrasonography revealed the characteristic findings of SAT. Patient 2, a 36-year-old Japanese woman, was inoculated twice with a SARS-CoV-2 vaccine (mRNA-1273; Moderna, Cambridge, MA, USA). She developed fever (37.8 °C) and thyroid gland pain on day 3 after the second vaccination. Blood chemistry tests revealed thyrotoxicosis and elevated serum CRP, TSAb, and antithyroid-stimulating hormone receptor antibody levels. Fever and thyroid gland pain persisted. Thyroid ultrasonography revealed the characteristic findings of SAT (i.e., slight swelling and a focal hypoechoic area with decreased blood flow). Prednisolone treatment was effective for SAT. However, thyrotoxicosis causing palpitations relapsed thereafter, for which thyroid scintigraphy with technetium pertechnetate was conducted, and the patient was diagnosed with GD. Thiamazole treatment was then initiated, which led to improvement in symptoms.

Conclusion: HLA typing revealed that both patients had the HLA-B*35:01, -C*04:01, and -DPB1*05:01 alleles. Only patient 2 had the HLA-DRB1*11:01 and HLA-DQB1*03:01 alleles. The HLA-B*35:01 and HLA-C*04:01 alleles appeared to be involved in the pathogenesis of SAT after SARS-CoV-2 vaccination, and the HLA-DRB1*11:01 and HLA-DQB1*03:01 alleles were speculated to be involved in the postvaccination pathogenesis of GD.

Citing Articles

Diagnosis of Graves' Disease during Treatment for Subacute Thyroiditis.

Yuuki M, Kurasaki K, Murata M, Matsuda M, Hata Y, Horiguchi K Intern Med. 2024; 63(21):2949-2952.

PMID: 39231676 PMC: 11604395. DOI: 10.2169/internalmedicine.3923-24.


SARS-CoV-2-Vaccine-Related Endocrine Disorders: An Updated Narrative Review.

Ishay A, Oleinikov K, Chertok Shacham E Vaccines (Basel). 2024; 12(7).

PMID: 39066388 PMC: 11281608. DOI: 10.3390/vaccines12070750.


Post-COVID-19 Vaccination and Thyrotoxicosis (ASIA Syndrome): Single-Centre Experience from India with Review of Literature.

Singhal V, Gupta S Indian J Endocrinol Metab. 2024; 27(6):524-529.

PMID: 38371178 PMC: 10871005. DOI: 10.4103/ijem.ijem_202_23.


Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso.

Ouedraogo A, Traore L, Ouattara A, Ouedraogo A, Zongo S, Savadogo M BMC Med Genomics. 2023; 16(1):246.

PMID: 37845715 PMC: 10577973. DOI: 10.1186/s12920-023-01684-8.


New-onset and relapsed Graves' disease following COVID-19 vaccination: a comprehensive review of reported cases.

Chen K, Gao Y, Li J Eur J Med Res. 2023; 28(1):232.

PMID: 37443067 PMC: 10339579. DOI: 10.1186/s40001-023-01210-7.


References
1.
Dong R, Kimura A, Okubo R, Shinagawa H, Tamai H, Nishimura Y . HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum Immunol. 1992; 35(3):165-72. DOI: 10.1016/0198-8859(92)90101-r. View

2.
Lee K, Kim Y, Jin H . Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review. Endocrine. 2021; 74(3):470-472. PMC: 8507356. DOI: 10.1007/s12020-021-02898-5. View

3.
Dechairo B, Zabaneh D, Collins J, Brand O, Dawson G, Green A . Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet. 2005; 13(11):1223-30. DOI: 10.1038/sj.ejhg.5201485. View

4.
Suzuki S, Midorikawa S, Fukushima T, Shimura H, Ohira T, Ohtsuru A . Systematic determination of thyroid volume by ultrasound examination from infancy to adolescence in Japan: the Fukushima Health Management Survey. Endocr J. 2015; 62(3):261-8. DOI: 10.1507/endocrj.EJ14-0478. View

5.
Bostan H, Sencar M, Calapkulu M, Kayihan S, Hepsen S, Cimsir A . Impact of the COVID-19 pandemic on the incidence, seasonal distribution, and characteristics of subacute thyroiditis. Endocrine. 2022; 79(2):323-330. PMC: 9490701. DOI: 10.1007/s12020-022-03197-3. View